There is sufficient evidence to support vitamin D’s noncalcemic effects and the role of
vitamin D deficiency in the development of a wide range of neurological disorders. This study aimed to evaluate
whether serum 25(OH)D and 1,25(OH) 2 D could be used as biomarkers to differentiate between healthy subjects
(HS), multiple system atrophy (MSA) and Parkinson’s disease (PD) patients of both genders. CLICK TO REVIEW